参考文献

［1］Mayo C, Yorke E, Merchant TE. Radiation associated brainstem injury. Int J RadiatOncol-Biol Phys, 2010, 76 (3): S36-S41.

［2］Yang-Chan Li, Fo-Ping Chen, Guan-Qun Zhou, et al. Incidence and dosimetric parameters for brainstem necrosis following intensity modulated radiation therapy in nasopharyngeal carcinoma. Oral Oncol, 2017, 73: 97-104.

［3］Lee N, Harris J, Garden AS, et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase Ⅱtrial 0225. J ClinOncol, 2009, 27 (22): 3684-3690.

［4］Lee NY, Zhang Q, Pfister DG, et al. Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multiinstitutional trial. Lancet Oncol, 2012, 13 (2): 172-180.

［5］Lee AW, Ng WT, Pan JJ, et al. International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys, 2019, 105 (3): 567-580.

［6］M Baumann, V Budach, S Appold. Radiation tolerance of the human spinal cord. Strahlenther Onkol, 1994, 170 (3): 131-139.